Pages with the fewest revisions

Jump to navigation Jump to search

Showing below up to 50 results in range #41,951 to #42,000.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. Acute uric acid nephropathy risk factors (2 revisions)
  2. Acute uric acid nephropathy screening (2 revisions)
  3. Acute uric acid nephropathy secondary prevention (2 revisions)
  4. Acute uric acid nephropathy surgery (2 revisions)
  5. Acute uric acid nephropathy ultrasound (2 revisions)
  6. Acute viral nasopharyngitis (common cold) classification (2 revisions)
  7. Acute viral nasopharyngitis Screening (2 revisions)
  8. Acyclovir (patient information) (2 revisions)
  9. Acyclovir clinical pharmacology (2 revisions)
  10. Acyclovir overdosage (2 revisions)
  11. Acyclovir warnings and precautions (2 revisions)
  12. Acyl (2 revisions)
  13. Acyl-CoA:lysocardiolipin acyltransferase-1 (2 revisions)
  14. Acyl-CoA thioesterase 9 (2 revisions)
  15. Acyl-coa synthetase medium chain family member 2a (2 revisions)
  16. Acyl halide (2 revisions)
  17. Acyltransferase like 2 (2 revisions)
  18. Adagrasib (2 revisions)
  19. Adalimumab sandbox (2 revisions)
  20. Adaptation to extrauterine life (2 revisions)
  21. Adapter molecule crk (2 revisions)
  22. Adaptogen (2 revisions)
  23. Adaptor-related protein complex 2, alpha 1 (2 revisions)
  24. Addison's disease case study one (2 revisions)
  25. Addison's disease screening (2 revisions)
  26. Addison-Gull syndrome (2 revisions)
  27. Additional sex combs like 2, transcriptional regulator (2 revisions)
  28. Addressin (2 revisions)
  29. Adduct (2 revisions)
  30. Adducted thumb syndrome (2 revisions)
  31. Adductor magnus muscle (2 revisions)
  32. Adecatumumab (2 revisions)
  33. Adefovir adverse reactions (2 revisions)
  34. Adefovir clinical pharmacology (2 revisions)
  35. Adefovir indications and usage (2 revisions)
  36. Adenitis case study one (2 revisions)
  37. Adenocarcinoma of the lung Intervention (2 revisions)
  38. Adenocarcinoma of the lung MRI (2 revisions)
  39. Adenocarcinoma of the lung medical therapy metastatic cancer (2 revisions)
  40. Adenocarcinoma of the lung medical therapy stage II (2 revisions)
  41. Adenocarcinoma of the lung medical therapy stage III (2 revisions)
  42. Adenocarcinoma of the lung medical therapy stage IV (2 revisions)
  43. Adenoid (2 revisions)
  44. Adenoidectomy (2 revisions)
  45. Adenoiditis (patient information) (2 revisions)
  46. Adenoma cost-effectiveness of therapy (2 revisions)
  47. Adenoma echocardiography or ultrasound (2 revisions)
  48. Adenoma future or investigational therapies (2 revisions)
  49. Adenoma of the thyroid (patient information) (2 revisions)
  50. Adenoma of the thyroid pathophysiology (2 revisions)

View ( | ) (20 | 50 | 100 | 250 | 500)